FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
758 letters match. Newest first.
-
DrugsGlobal Pharma Healthcare Private Limited
FDA warned Global Pharma Healthcare that non-sterile artificial tears and eye ointment from its India plant were tied to a Pseudomonas outbreak with four deaths.
High risk -
FoodAmerican Distribution and Manufacturing Co., LLC
FDA found American Distribution and Manufacturing lacked required foreign supplier verification for imported pet food and feed additive.
Medium -
FoodGondi S.A.
FDA warns Ecuadorian canned seafood maker Gondi S.A. after finding underprocessed low-acid canned shrimp and sardines linked to recalls and an import alert.
High risk -
DevicesMing Fai Industrial Co LTD
Ming Fai Industrial, a Shenzhen device maker, lacked validation and acceptance-status controls for ultrasound gel and probe covers.
High risk -
DrugsALI Pharmaceutical Manufacturing, LLC
FDA says ALI Pharmaceutical Manufacturing failed to validate and control its porcine thyroid drug substance process, making the drug substance adulterated.
High risk -
BiologicsAbbott Laboratories
FDA warns Abbott that Similac Probiotic Tri-Blend for preterm infants is an unapproved drug and adulterated supplement.
High risk -
AnimalEmbryll Life Sciences, Inc.
FDA warns Embryll Life Sciences that it sells unapproved Lanomax eye drops to treat cataracts in animals.
High risk -
DrugsSun Pharmaceutical Industries Ltd.
FDA warns Sun Pharmaceutical over CGMP violations in sterile injectable manufacturing at its Halol, India facility.
High risk -
DrugsSeoul Cosmetics Co., Ltd.
FDA warned Seoul Cosmetics, a South Korean drug maker, over poor manufacturing quality and unapproved OTC drugs.
High risk -
FoodFanta Seafoods
FDA warned Fanta Seafoods that serious seafood safety plan (HACCP) and sanitation failures at its Guyana plant made mackerel and shrimp adulterated.
High risk -
DevicesAbiomed Inc.
Abiomed marketed Impella Connect System without PMA and had CGMP, complaint, and MDR reporting failures.
High risk -
DrugsSouthern Tier Home Infusion, Inc. dba Pharmacy Innovations
FDA warned compounding pharmacy Pharmacy Innovations that its sterile drugs were made under insanitary conditions and without valid patient prescriptions.
High risk -
BiologicsSignature Biologics, LLC
FDA cited Signature Biologics for unapproved, unlicensed Signature Cord and serious sterile manufacturing failures.
High risk -
BiologicsFresenius Kabi AG
FDA warned Fresenius Kabi’s Fenwal plant in Puerto Rico about unsafe manufacturing of blood-pack units and solutions.
High risk -
DrugsZhao Qing Longda Biotechnology Co. Ltd.
FDA says Zhao Qing Longda Biotechnology refused records access for OTC drugs, including children’s toothpaste, and placed its drugs on import alert.
High risk -
DrugsGulf States International, Inc.
Gulf States International refused FDA requests for OTC drug manufacturing records, FDA says.
Medium -
FoodPT. Winson Prima Sejahtera
FDA says PT. Winson Prima Sejahtera's ready-to-eat yellowfin tuna seafood safety plan lacks pathogen and histamine controls.
High risk -
DrugsMaison Blanche LLC
FDA warns Maison Blanche for refusing repeated requests for records on its OTC hand sanitizer.
Medium -
DrugsKor-Chem, Inc.
Kor-Chem, Inc. made OTC hand sanitizer drugs with manufacturing violations, including shared equipment with industrial chemicals and missing identity and microbial testing.
High risk -
DrugsSimilasan AG
Similasan AG's ophthalmic drugs are unapproved new drugs and violate CGMP (manufacturing quality rules), FDA says.
High risk -
FoodReckitt/Mead Johnson Nutrition
FDA warned Reckitt/Mead Johnson over Cronobacter contamination and inadequate process controls at two powdered infant formula plants.
High risk -
FoodByHeart, Inc.
FDA warns ByHeart that Cronobacter contamination in infant formula and weak investigations led to release of adulterated powdered formula.
High risk -
FoodPerrigo Wisconsin, LLC
FDA found Cronobacter in Perrigo infant formula and facility; company recalled some Gerber Good Start Soothe Pro.
High risk -
AnimalEssential Research, LLC
FDA warned Essential Research that its Chocolate Rescue for Dogs is an unapproved new animal drug sold with unproven treatment claims.
High risk -
DrugsK.C. Pharmaceuticals Inc.
FDA warned K.C. Pharmaceuticals after inspections found manufacturing rule violations in sterile ophthalmic drugs, including inadequate contamination controls and cleaning validation.
High risk -
FoodAmor Nino Foods, Inc.
FDA says Amor Nino Foods' ready-to-eat Hawaiian-style aku tuna sticks were made under an inadequate seafood safety plan and without required monitoring.
High risk -
FoodVictory Trading Company Inc.
FDA warns Victory Trading after finding widespread rodent infestation in its Greenland, NH food warehouse.
High risk -
DevicesKing Systems Corp. dba Ambu, Inc.
FDA warns Ambu's King Systems over unapproved King LTS-D airway device and pediatric website claims.
High risk -
DrugsDenison Pharmaceuticals, LLC
Denison Pharmaceuticals was cited for manufacturing quality failures, contamination risks, and unapproved infant/homeopathic drugs.
High risk -
DrugsCergomex Imports, LLC
Cergomex Imports, an over-the-counter drug manufacturer, refused FDA records requests for its Sanetto Hands Sanitizer Gel.
Medium -
DrugsGTP International Corp
GTP International, a Mesquite, TX maker of OTC hand sanitizer, refused FDA's repeated requests for manufacturing records.
Medium -
DrugsSuhan Aerosol
Suhan Aerosol, an Indian OTC drug maker, failed to test high-risk ingredients for toxic diethylene/ethylene glycol and lacked quality oversight.
High risk -
DrugsSkyline Herbals Private Limited
FDA warns India's Skyline Herbals after it ignored records requests for OTC drugs including toothpaste; all its drugs hit Import Alert 66-79.
High risk -
DrugsDaxal Cosmetics Private Limited
FDA warns Daxal Cosmetics for refusing records on over-the-counter drugs, including toothpaste, at risk for diethylene glycol and ethylene glycol contamination.
High risk -
DrugsOrchid Lifesciences
FDA warns Orchid Lifesciences over over-the-counter drug testing gaps and weak quality unit.
High risk -
DrugsUS Specialty Formulations, LLC
US Specialty Formulations, a drug compounder registered as an outsourcing facility, made sterile compounded drugs under insanitary conditions.
High risk -
FoodSTC India Private Limited
FDA warned STC India over insanitary conditions and missing Salmonella controls for ready-to-eat mukhwas.
High risk -
DrugsIntas Pharmaceuticals Limited
FDA warned Intas Pharmaceuticals about serious manufacturing-quality violations, including data integrity failures and inaccurate environmental monitoring, at its India drug plant.
High risk -
DrugsBaxter Healthcare Corporation
FDA warned Baxter over CGMP violations at its India plant, including inadequate endotoxin and visual inspection investigations for sterile injectables.
High risk -
DrugsCentaur Pharmaceuticals Private Ltd.
FDA says Centaur Pharmaceuticals drugs were adulterated due to inadequate cleaning and cross-contamination.
High risk -
DrugsMedgel Private Limited
FDA cited Medgel Private Limited, an Indian OTC drug maker, for manufacturing violations including poor investigations and data integrity failures.
High risk -
DrugsIso-Tex Diagnostics, Inc.
FDA warns Iso-Tex Diagnostics over manufacturing violations that risk contamination of sterile radiopharmaceutical drugs.
High risk -
DrugsAvlon Industries, Inc.
FDA warned Avlon Industries that its over-the-counter drug manufacturing broke quality rules, citing missing identity tests for high-risk glycerin/propylene glycol and validation failures.
High risk -
FoodPremier Food Supplies LLC
FDA says Premier Food Supplies lacked an FSVP for imported snack and pickle products.
Medium -
BiologicsRenatiLabs Inc.
RenatiLabs marketed WJMAX, a human umbilical cord-derived biologic, without a license and released a lot that failed sterility testing.
High risk -
AnimalFive Leaf Pet Botanicals, Inc.
Five Leaf Pet Botanicals marketed unapproved animal drugs for dogs with disease-treatment claims on its websites.
Medium -
BiologicsStratus Biosystems, LLC dba CellGenuity Regenerative Science
FDA warns CellGenuity over unapproved amniotic/umbilical products and serious sterility failures.
High risk -
FoodChean Industries Dominicana S.R.L.
FDA warns Chean Industries Dominicana over dried sea cucumbers lacking HACCP controls and sanitation records.
High risk -
DevicesOutset Medical, Inc.
FDA warns Outset Medical over unapproved TabloCart and promotion of Tablo dialysis system for unapproved CRRT use.
High risk -
DrugsFuller Industries Inc.
FDA warns Fuller Industries over current good manufacturing practice violations in OTC hand soaps and sanitizers, including quality oversight and ingredient testing.
High risk